Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Obstructive Lung Diseases

  Free Subscription


Articles published in Curr Opin Pulm Med

Retrieve available abstracts of 90 articles:
HTML format



Single Articles


    January 2021
  1. BOULET LP, Cote A, Abd-Elaziz K, Gauvreau G, et al
    Allergen bronchoprovocation test: an important research tool supporting precision medicine.
    Curr Opin Pulm Med. 2021;27:15-22.
    PubMed     Abstract available


    October 2020
  2. DIAMANT Z, Hanania NA
    Dealing with asthma during the turbulent times of coronavirus disease-2019.
    Curr Opin Pulm Med. 2020 Oct 21. doi: 10.1097/MCP.0000000000000745.
    PubMed    


  3. RAMASWAMY US, Patel VA, Lee SE
    Managing chronic rhinosinusitis in severe asthma.
    Curr Opin Pulm Med. 2020 Oct 21. doi: 10.1097/MCP.0000000000000741.
    PubMed     Abstract available


  4. BLAKE KV
    Telemedicine and adherence monitoring in children with asthma.
    Curr Opin Pulm Med. 2020 Oct 21. doi: 10.1097/MCP.0000000000000739.
    PubMed     Abstract available


  5. ASSAF SM, Tarasevych SP, Diamant Z, Hanania NA, et al
    Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps.
    Curr Opin Pulm Med. 2020 Oct 16. doi: 10.1097/MCP.0000000000000744.
    PubMed     Abstract available


  6. ABD-ELAZIZ K, Jesenak M, Vasakova M, Diamant Z, et al
    Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases.
    Curr Opin Pulm Med. 2020 Oct 16. doi: 10.1097/MCP.0000000000000743.
    PubMed     Abstract available


  7. KAO CC, Hanania NA, Parulekar AD
    The impact of fungal allergic sensitization on asthma.
    Curr Opin Pulm Med. 2020 Oct 6. doi: 10.1097/MCP.0000000000000740.
    PubMed     Abstract available


    September 2020
  8. WU TD
    Diabetes, insulin resistance, and asthma: a review of potential links.
    Curr Opin Pulm Med. 2020 Sep 29. doi: 10.1097/MCP.0000000000000738.
    PubMed     Abstract available


  9. QUIRCE S, Dominguez-Ortega J, Luna JA
    Novel approaches in occupational asthma diagnosis and management.
    Curr Opin Pulm Med. 2020 Sep 21. doi: 10.1097/MCP.0000000000000737.
    PubMed     Abstract available


    July 2020
  10. HARDER EM, Waxman AB
    Clinical trials in group 3 pulmonary hypertension.
    Curr Opin Pulm Med. 2020 Jul 9. doi: 10.1097/MCP.0000000000000694.
    PubMed     Abstract available


    March 2020
  11. MCDONALD CF
    Eosinophils in chronic obstructive pulmonary disease: are they just another biomarker?
    Curr Opin Pulm Med. 2020;26:169-174.
    PubMed     Abstract available


  12. RATARASARN K, Kundu A
    Yoga and Tai Chi: a mind-body approach in managing respiratory symptoms in obstructive lung diseases.
    Curr Opin Pulm Med. 2020;26:186-192.
    PubMed     Abstract available


  13. WILES SP, Aboussouan LS, Mireles-Cabodevila E
    Noninvasive positive pressure ventilation in stable patients with COPD.
    Curr Opin Pulm Med. 2020;26:175-185.
    PubMed     Abstract available


  14. ALBITAR HAH, Iyer VN
    Adherence to Global Initiative for Chronic Obstructive Lung Disease guidelines in the real world: current understanding, barriers, and solutions.
    Curr Opin Pulm Med. 2020;26:149-154.
    PubMed     Abstract available


  15. SINGH D, Long G, Cancado JED, Higham A, et al
    Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinician.
    Curr Opin Pulm Med. 2020;26:162-168.
    PubMed     Abstract available


    February 2020
  16. SPECJALSKI K, Niedoszytko M
    MicroRNAs: future biomarkers and targets of therapy in asthma?
    Curr Opin Pulm Med. 2020 Feb 25. doi: 10.1097/MCP.0000000000000673.
    PubMed     Abstract available


    January 2020
  17. CHRISTENSON SA
    The role of genomic profiling in identifying molecular phenotypes in obstructive lung diseases.
    Curr Opin Pulm Med. 2020;26:84-89.
    PubMed     Abstract available


  18. ULRIK CS, Vijverberg S, Hanania NA, Diamant Z, et al
    Precision medicine and treatable traits in chronic airway diseases - where do we stand?
    Curr Opin Pulm Med. 2020;26:33-39.
    PubMed     Abstract available


  19. GAUVREAU GM, White L, Davis BE
    Anti-alarmin approaches entering clinical trials.
    Curr Opin Pulm Med. 2020;26:69-76.
    PubMed     Abstract available


    November 2019
  20. DIAMANT Z, van den Berge M, Hanania NA
    Asthma: a modifiable disease on a crossroad.
    Curr Opin Pulm Med. 2019 Nov 12. doi: 10.1097/MCP.0000000000000650.
    PubMed    


  21. PITZNER-FABRICIUS A, Toennesen LL, Backer V
    Can training induce inflammatory control in asthma, or is it symptom control only?
    Curr Opin Pulm Med. 2019 Nov 12. doi: 10.1097/MCP.0000000000000648.
    PubMed     Abstract available


  22. BONTINCK A, Maes T, Joos G
    Asthma and air pollution: recent insights in pathogenesis and clinical implications.
    Curr Opin Pulm Med. 2019 Nov 12. doi: 10.1097/MCP.0000000000000644.
    PubMed     Abstract available


  23. VENKATA AN
    Asthma-COPD overlap: review of diagnosis and management.
    Curr Opin Pulm Med. 2019 Nov 9. doi: 10.1097/MCP.0000000000000649.
    PubMed     Abstract available


  24. VAN DER VEEN TA, de Groot LES, Melgert BN
    The different faces of the macrophage in asthma.
    Curr Opin Pulm Med. 2019 Nov 7. doi: 10.1097/MCP.0000000000000647.
    PubMed     Abstract available


  25. SANCHEZ-GARCIA S, Rial MJ, Dominguez-Ortega J
    Long and winding road: from infant wheeze to adult asthma.
    Curr Opin Pulm Med. 2019 Nov 4. doi: 10.1097/MCP.0000000000000643.
    PubMed     Abstract available


    October 2019
  26. BAHMER T, Sand JMB, Weckmann M
    Lost in transition: biomarkers of remodeling in patients with asthma.
    Curr Opin Pulm Med. 2019 Oct 24. doi: 10.1097/MCP.0000000000000641.
    PubMed     Abstract available


  27. LU KD, Forno E
    Exercise and lifestyle changes in pediatric asthma.
    Curr Opin Pulm Med. 2019 Oct 24. doi: 10.1097/MCP.0000000000000636.
    PubMed     Abstract available


  28. ROGLIANI P, Sforza M, Calzetta L
    The impact of comorbidities on severe asthma.
    Curr Opin Pulm Med. 2019 Oct 21. doi: 10.1097/MCP.0000000000000640.
    PubMed     Abstract available


  29. SLISZ T, Vasakova M
    The burden of corticosteroid overload in severe and difficult to treat asthma: how to reduce this?
    Curr Opin Pulm Med. 2019 Oct 9. doi: 10.1097/MCP.0000000000000635.
    PubMed     Abstract available


    September 2019
  30. VIJVERBERG SJH, Brinkman P, Rutjes NWP, Maitland-van der Zee AH, et al
    Precision medicine in severe pediatric asthma: opportunities and challenges.
    Curr Opin Pulm Med. 2019 Sep 30. doi: 10.1097/MCP.0000000000000633.
    PubMed     Abstract available


  31. KOZIK A, Huang YJ
    Ecological interactions in asthma: from environment to microbiota and immune responses.
    Curr Opin Pulm Med. 2019 Sep 24. doi: 10.1097/MCP.0000000000000632.
    PubMed     Abstract available


    March 2019
  32. CHANG-MACCHIU P, Traversi L, Polverino E
    Bronchiectasis phenotypes.
    Curr Opin Pulm Med. 2019 Mar 18. doi: 10.1097/MCP.0000000000000569.
    PubMed     Abstract available


  33. DUNLAP DG, Semaan R, Riley CM, Sciurba FC, et al
    Bronchoscopic device intervention in chronic obstructive pulmonary disease.
    Curr Opin Pulm Med. 2019;25:201-210.
    PubMed     Abstract available


  34. WANG J, Cao B
    Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance.
    Curr Opin Pulm Med. 2019;25:158-164.
    PubMed     Abstract available


  35. MANNINO DM
    Biomarkers for chronic obstructive pulmonary disease diagnosis and progression: insights, disappointments and promise.
    Curr Opin Pulm Med. 2019;25:144-149.
    PubMed     Abstract available


  36. MOON JY, Sin DD
    Inhaled corticosteroids and fractures in chronic obstructive pulmonary disease: current understanding and recommendations.
    Curr Opin Pulm Med. 2019;25:165-172.
    PubMed     Abstract available


  37. BURKES RM, Drummond MB
    Initiating drug therapy in early stage chronic obstructive pulmonary disease: does it impact the course and outcome?
    Curr Opin Pulm Med. 2019;25:132-137.
    PubMed     Abstract available


  38. AMARIEI DE, Reed RM
    The role of statins in chronic obstructive pulmonary disease: is cardiovascular disease the common denominator?
    Curr Opin Pulm Med. 2019;25:173-178.
    PubMed     Abstract available


  39. CHAN HP, Lim TK
    Procalcitonin and antibiotics in moderate-severe acute exacerbation of chronic obstructive pulmonary disease: to use or not to use.
    Curr Opin Pulm Med. 2019;25:150-157.
    PubMed     Abstract available


    February 2019
  40. RATHNAYAKE SNH, Van den Berge M, Faiz A
    Genetic profiling for disease stratification in chronic obstructive pulmonary disease and asthma.
    Curr Opin Pulm Med. 2019 Feb 11. doi: 10.1097/MCP.0000000000000568.
    PubMed     Abstract available


    January 2019
  41. KOCUREK EG, Jagana R
    Noncystic fibrosis bronchiectasis management: opportunities and challenges.
    Curr Opin Pulm Med. 2019 Jan 10. doi: 10.1097/MCP.0000000000000562.
    PubMed     Abstract available


  42. BRINKMAN P, Zee AM, Wagener AH
    Breathomics and treatable traits for chronic airway diseases.
    Curr Opin Pulm Med. 2019;25:94-100.
    PubMed     Abstract available


    November 2018
  43. PEREZ-MIRANDA J, Traversi L, Polverino E
    Bronchiectasis in severe asthma: a distinct phenotype?
    Curr Opin Pulm Med. 2018 Nov 16. doi: 10.1097/MCP.0000000000000542.
    PubMed     Abstract available


  44. PAVORD ID
    Oral corticosteroid-dependent asthma: current knowledge and future needs.
    Curr Opin Pulm Med. 2018 Nov 16. doi: 10.1097/MCP.0000000000000541.
    PubMed     Abstract available


  45. ROMAN-RODRIGUEZ M, Metting E, Gacia-Pardo M, Kocks J, et al
    Wrong inhalation technique is associated to poor asthma clinical outcomes. Is there room for improvement?
    Curr Opin Pulm Med. 2018 Nov 15. doi: 10.1097/MCP.0000000000000540.
    PubMed     Abstract available


  46. BOULET LP, Hanania NA
    The many faces of asthma-chronic obstructive pulmonary disease overlap.
    Curr Opin Pulm Med. 2018 Nov 15. doi: 10.1097/MCP.0000000000000547.
    PubMed     Abstract available


  47. PELOZA DL, Jackson DJ
    Strategies to prevent exacerbations of childhood asthma.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000539.
    PubMed     Abstract available


  48. ERJEFALT JS
    Unravelling the complexity of tissue inflammation in uncontrolled and severe asthma.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000536.
    PubMed     Abstract available


  49. SEYS SF, Lokwani R, Simpson JL, Bullens DMA, et al
    New insights in neutrophilic asthma.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000543.
    PubMed     Abstract available


  50. DIAMANT Z, Aalders W, Parulekar A, Bjermer L, et al
    Targeting lipid mediators in asthma: time for reappraisal.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000544.
    PubMed     Abstract available


  51. ROBIJN AL, Murphy VE, Gibson PG
    Recent developments in asthma in pregnancy.
    Curr Opin Pulm Med. 2018 Nov 6. doi: 10.1097/MCP.0000000000000538.
    PubMed     Abstract available


  52. VAN DEN BERGE M, Tasena H
    Role of microRNAs and exosomes in asthma.
    Curr Opin Pulm Med. 2018 Nov 1. doi: 10.1097/MCP.0000000000000532.
    PubMed     Abstract available


  53. GRACE J, Mohan A, Lugogo NL
    Obesity and adult asthma: diagnostic and management challenges.
    Curr Opin Pulm Med. 2018 Nov 1. doi: 10.1097/MCP.0000000000000531.
    PubMed     Abstract available


    October 2018
  54. LANG JE
    Obesity and childhood asthma.
    Curr Opin Pulm Med. 2018 Oct 16. doi: 10.1097/MCP.0000000000000537.
    PubMed     Abstract available


  55. HERRERA-LUIS E, Hernandez-Pacheco N, Vijverberg SJ, Flores C, et al
    Role of genomics in asthma exacerbations.
    Curr Opin Pulm Med. 2018 Oct 16. doi: 10.1097/MCP.0000000000000533.
    PubMed     Abstract available


  56. QUIRCE S, Sastre J
    Occupational asthma: clinical phenotypes, biomarkers, and management.
    Curr Opin Pulm Med. 2018 Oct 12. doi: 10.1097/MCP.0000000000000535.
    PubMed     Abstract available


    September 2018
  57. KAVANAGH J, Jackson DJ, Kent BD
    Sleep and asthma.
    Curr Opin Pulm Med. 2018 Sep 7. doi: 10.1097/MCP.0000000000000526.
    PubMed     Abstract available


    May 2018
  58. VAN MOORSEL CHM
    Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease.
    Curr Opin Pulm Med. 2018;24:309-317.
    PubMed     Abstract available


    March 2018
  59. HATIPOGLU U, Stoller JK
    Supplemental oxygen in patients with stable chronic obstructive pulmonary disease: evidence from Nocturnal Oxygen Treatment Trial to Long-term Oxygen Treatment Trial.
    Curr Opin Pulm Med. 2018;24:179-186.
    PubMed     Abstract available


  60. BARRECHEGUREN M, Bourbeau J
    Self-management strategies in chronic obstructive pulmonary disease: a first step toward personalized medicine.
    Curr Opin Pulm Med. 2018;24:191-198.
    PubMed     Abstract available


  61. DAS N, Topalovic M, Janssens W
    Artificial intelligence in diagnosis of obstructive lung disease: current status and future potential.
    Curr Opin Pulm Med. 2018;24:117-123.
    PubMed     Abstract available


  62. KAKKERA K, Padala KP, Kodali M, Padala PR, et al
    Association of chronic obstructive pulmonary disease with mild cognitive impairment and dementia.
    Curr Opin Pulm Med. 2018;24:173-178.
    PubMed     Abstract available


  63. IYER VN
    Low-dose oxygen therapy in COPD patients: are there any radiation-like risks?
    Curr Opin Pulm Med. 2018;24:187-190.
    PubMed     Abstract available


  64. SIDDIQUI FM, Diamond JM
    Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions.
    Curr Opin Pulm Med. 2018;24:199-204.
    PubMed     Abstract available


  65. BISWAS A, Mehta HJ, Folch EE
    Chronic obstructive pulmonary disease and lung cancer: inter-relationships.
    Curr Opin Pulm Med. 2018;24:152-160.
    PubMed     Abstract available


  66. PRESS VG, Konetzka RT, White SR
    Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program.
    Curr Opin Pulm Med. 2018;24:138-146.
    PubMed     Abstract available


  67. SPENCER L
    Pulmonary rehabilitation for patients with acute chronic obstructive pulmonary disease exacerbations: is the evidence strengthening?
    Curr Opin Pulm Med. 2018;24:147-151.
    PubMed     Abstract available


  68. KRISHNAN JK, Martinez FJ
    Lung function trajectories and chronic obstructive pulmonary disease: current understanding and knowledge gaps.
    Curr Opin Pulm Med. 2018;24:124-129.
    PubMed     Abstract available


  69. DEAS SD, Huprikar N
    Dual bronchodilator therapy for chronic obstructive pulmonary disease: evidence for the efficacy and Safety of fixed dose combination treatments in the setting of recent guideline updates.
    Curr Opin Pulm Med. 2018;24:130-137.
    PubMed     Abstract available


    January 2018
  70. FINGLETON J, Hardy J, Beasley R
    Treatable traits of chronic airways disease.
    Curr Opin Pulm Med. 2018;24:24-31.
    PubMed     Abstract available


    December 2017
  71. CHATTERJEE K, Tarawneh AR, Alam S
    Out of proportion pulmonary hypertension in obstructive lung diseases.
    Curr Opin Pulm Med. 2017 Dec 18. doi: 10.1097/MCP.0000000000000457.
    PubMed     Abstract available


    November 2017
  72. CARPAIJ OA, van den Berge M
    The asthma-obesity relationship: underlying mechanisms and treatment implications.
    Curr Opin Pulm Med. 2017 Nov 23. doi: 10.1097/MCP.0000000000000446.
    PubMed     Abstract available


    October 2017
  73. KOCKS JWH, Seys SF, van Duin TS, Diamant Z, et al
    Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice?
    Curr Opin Pulm Med. 2017 Oct 27. doi: 10.1097/MCP.0000000000000447.
    PubMed     Abstract available


  74. AL-SAJEE D, Oliveria JP, Sehmi R, Gauvreau GM, et al
    Antialarmins for treatment of asthma: future perspectives.
    Curr Opin Pulm Med. 2017 Oct 27. doi: 10.1097/MCP.0000000000000443.
    PubMed     Abstract available


  75. NYENHUIS SM, Apter AJ, Schatz M, Krishnan JA, et al
    Comparative effectiveness trials in asthma - how will I recognize one?
    Curr Opin Pulm Med. 2017 Oct 25. doi: 10.1097/MCP.0000000000000442.
    PubMed     Abstract available


  76. BOULET LP
    Airway remodeling in asthma: update on mechanisms and therapeutic approaches.
    Curr Opin Pulm Med. 2017 Oct 25. doi: 10.1097/MCP.0000000000000441.
    PubMed     Abstract available


  77. PITE H, Morais-Almeida M, Rocha SM
    Metabolomics in asthma: where do we stand?
    Curr Opin Pulm Med. 2017 Oct 20. doi: 10.1097/MCP.0000000000000437.
    PubMed     Abstract available


  78. HUMBERT M, Busse W, Hanania NA
    Controversies and opportunities in severe asthma.
    Curr Opin Pulm Med. 2017 Oct 20. doi: 10.1097/MCP.0000000000000438.
    PubMed     Abstract available


  79. HANANIA NA, Diamant Z
    The road to precision medicine in asthma: challenges and opportunities.
    Curr Opin Pulm Med. 2017 Oct 17. doi: 10.1097/MCP.0000000000000444.
    PubMed    


  80. BONINI M, Usmani OS
    Novel methods for device and adherence monitoring in asthma.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000439.
    PubMed     Abstract available


  81. PARULEKAR AD, Kao CC, Diamant Z, Hanania NA, et al
    Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000436.
    PubMed     Abstract available


  82. CHUNG KF
    Precision medicine in asthma: linking phenotypes to targeted treatments.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000434.
    PubMed     Abstract available


  83. BRAIDO F, Baiardini I, Canonica GW
    Patient-reported outcomes in asthma clinical trials.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000440.
    PubMed     Abstract available


    March 2017
  84. ALTER A, Aboussouan LS, Mireles-Cabodevila E
    Neuromuscular weakness in chronic obstructive pulmonary disease: chest wall, diaphragm, and peripheral muscle contributions.
    Curr Opin Pulm Med. 2017;23:129-138.
    PubMed     Abstract available


  85. KWO E, Christiani D
    The role of gene-environment interplay in occupational and environmental diseases: current concepts and knowledge gaps.
    Curr Opin Pulm Med. 2017;23:173-176.
    PubMed     Abstract available


  86. HARRINGTON SE, Rogers E, Davis M
    Palliative care and chronic obstructive pulmonary disease: where the lines meet.
    Curr Opin Pulm Med. 2017;23:154-160.
    PubMed     Abstract available


  87. TSAI SC
    Chronic obstructive pulmonary disease and sleep related disorders.
    Curr Opin Pulm Med. 2017;23:124-128.
    PubMed     Abstract available


  88. RAGHAVAN D, Varkey A, Bartter T
    Chronic obstructive pulmonary disease: the impact of gender.
    Curr Opin Pulm Med. 2017;23:117-123.
    PubMed     Abstract available


  89. HANSON C, LeVan T
    Obesity and chronic obstructive pulmonary disease: recent knowledge and future directions.
    Curr Opin Pulm Med. 2017;23:149-153.
    PubMed     Abstract available


  90. SEHGAL IS, Dhooria S, Agarwal R
    Chronic obstructive pulmonary disease and malnutrition in developing countries.
    Curr Opin Pulm Med. 2017;23:139-148.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: